Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cathay Venture

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
The average size of a deal this fund participated in
Portfolio companies 6
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Health Care
  • Pharmaceutical
  • Biotechnology
  • Medical Device
  • Therapeutics

The fund is generally included in less than 2 deals every year. Comparing to the other companies, this Cathay Venture performs on 12 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2016.

Among the most popular portfolio startups of the fund, we may highlight Rani Therapeutics, KKday, KKday. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, E-Commerce. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Cathay Venture, startups are often financed by GV, AppWorks, Novartis. The meaningful sponsors for the fund in investment in the same round are Substance Capital, Monku2019s Hill Ventures, MindWorks Ventures. In the next rounds fund is usually obtained by MindWorks Ventures, H.I.S., Substance Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cathay Venture:
Typical Co-investors
Cathay Venture is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cathay Venture:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Air Liquide Ventures France, Ile-de-France, Paris
Boston Life Science Venture Taipei, Taiwan
Croda International Plc United Kingdom, York, Yorkshire and the Humber
Eventide Risk Management -
First In Ventures -
GPB Capital Holdings New York, New York, United States
Jebsen & Jessen Germany, Hamburg
Jinkai High-tech Investment China, Japan, Kagoshima Prefecture
JNKS Investments -
Mingyuanyun China, Guangdong, Shenzhen
Narya Capital Illinois, Ohio, United States
Startup Sauna Espoo, Finland, Uusimaa
Sunfire Entrepreneurs Club -
The Progressive Corporation Bay Village, Ohio, United States
The Shimizu Bank Japan, Shizuoka, Shizuoka Prefecture
The Wolfen Group -
Topfonds Gelderland -
Youshan Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Financial Services
$30M09 May 2019 Kowloon, Hong Kong, China


Artificial Intelligence
Health Care
Health Diagnostics
Medical Device
$1M26 Mar 2019 New Taipei, Taiwan


3D Technology
Health Care
Information Technology
$20M11 Apr 2018 South Holland

Rani Therapeutics

$53M07 Feb 2018 San Jose, California, United States

Angiotech Pharmaceuticals

Health Care
Medical Device
21 Mar 2017 British Columbia


$7M04 Dec 2016 New Taipei, Taiwan


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cathay Venture?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: